TRIGGERING_EVENTS_OF_INTEREST = {
    "1.01": "Entry into a Material Definitive Agreement",  # M&A
    "1.02": "Termination of a Material Definitive Agreement",
    "2.01": "Completion of Acquisition or Disposition of Assets",
    "2.02": "Results of Operations and Financial Condition",
    "5.02": "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers",
}

OTHER_TRIGGERING_EVENTS = {
    "1.03": "Bankruptcy or Receivership",
    "1.04": "Mine Safety - Reporting of Shutdowns and Patterns of Violations",
    "2.03": "Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant",
    "2.04": "Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement",
    "2.05": "Costs Associated with Exit or Disposal Activities",
    "2.06": "Material Impairments",
    "3.01": "Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing",
    "3.02": "Unregistered Sales of Equity Securities",
    "3.03": "Material Modifications to Rights of Security Holders",
    "4.01": "Changes in Registrant's Certifying Accountant",
    "4.02": "Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review",
    "5.01": "Changes in Control of Registrant",
    "5.03": "Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year",
    "5.04": "Temporary Suspension of Trading Under Registrant's Employee Benefit Plans",
    "5.05": "Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics",
    "5.06": "Change in Shell Company Status",
    "5.07": "Submission of Matters to a Vote of Security Holders",
    "7.01": "Regulation FD Disclosure",
    "8.01": "Other Events",
    "9.01": "Financial Statements and Exhibits",
}

# 10-Q Inventory (Note 5)
# 10-Q RECENT DEVELOPMENTS / OTHER KEY DEVELOPMENTS (look for mentions of products)
# BIIB111 and BIIB112
# During the second quarter of 2021 we announced that our Phase 3 STAR study of BIIB111 did not meet its primary or key secondary
# endpoints. We reassessed the fair value of the program based on the results of this study and recognized an impairment charge of
# $350.0 million during the second quarter of 2021, which resulted in a reduction of the IPR&D intangible asset from $365.0 million to
# $15.0 million.
# COLLABORATIVE AND OTHER RELATIONSHIPS
# ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (per product)
# Early Stage Programs
# Late Stage Programs
